Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

283
innovative chemical compounds that are capable of treating diseases caused by bacteria
that are resistant to several drugs. It is extremely necessary to find novel compounds in
nature to produce new antibacterial compounds. In recent years, there has been a change
in secondary metabolites that are employed in antimicrobial medications. Actinobacteria has become the dominant source of these compounds. Marine bioactive chemicals
including polyphenols, proteins, and essential fatty acids possess different biological
effects such as antioxidant, antithrombotic, anticoagulant, anti-inflammatory, antiproliferative, hypotensive, diabetic, and cardioprotective properties (Table 13.1). The food
industry may also profit from the advantageous rheological qualities that they possess
(Ameen et al., 2021).
13.3 ANTICANCER ACTIVITY OF MARINE PLANTS
Almost 90% of the ocean’s total biomass comprises various types of marine flora. They
are plentiful, taxonomically varied, physiologically active, and chemically distinct, all of
which make them excellent candidates for the research that might lead to the development
of novel cancer therapies. Polyphenols with sulfated polysaccharides, for example, are two
examples of chemicals found in marine flora that may have medical use. The compounds
have shown a broad variety of pharmacological characteristics, including anticancer,
immunostimulatory, and antioxidant properties. It is possible that phytochemicals might
prevent carcinogenesis by boosting macrophage activity, causing cells to commit suicide
(apoptosis), and shielding DNA from oxidative damage. Sea plants contain large untapped
reserves that have been chemically enhanced, but researchers are most interested in possible
compounds that might combat cancer. This chapter ’s objective is to promote additional
research into the anticancer properties of marine flora in light of rising prevalence of
cancer and the lack of readily available, low-risk, and highly efficient medicines to treat
this dreadful human disease. Marine flora has been shown to possess these properties
(Manoharan and Perumal, 2022).
As a consequence of alterations in diet, changes in lifestyle, and increased environmental
stress, the incidence of cancer, a terrible illness that affects people, is on the rise. Cancer
treatments are now suffering from a lack of accessible medications that are effective, in part
because of the negative effects that are associated with the currently available treatments.
In this context, naturally occurring compounds that are produced from medicinal plants
have become more important. More than half of all medications that are administered in
clinical settings across the world are derived in some way from natural materials or are
produced by using these natural materials (Hegde and Chen, 2020). The contribution of
higher plants is guaranteed to be at least 25% of the total. Over 60% of cancer treatments
are derived from other natural sources. Fruits and vegetables include a high concentration
of cancer-ghting elements such as vitamins (B, C, and E), carotenoids, and ber. Fruits and
vegetables are also rich in antioxidants. The life expectancy increases in direct proportion
to the quantity of natural antioxidants that are eaten, decreasing the chances of occurrence
of cardiovascular diseases and cancer. During the last three decades, there has been a boom
of herbal medicine formulations for preventing and treating cancer, and research into

TABLE 13.1 Marine-Derived Bioactive Metabolites Along With Their Potential Applications (Nair and Abraham, 2020; Hamed et al., 2024)
S. No. Secondary Metabolites Marine Species Applications
Anticancerous
1. Aureoverticillactam
2. Caprolactones
3. Chinikomycins
4. IB-00208
5. Salinosporamide A (NPI-0052)
6. Urdamycin
7. Niphateolide
8. Hexylitaconic acid
9. Lissoclinidine B
10. Himeic acid A
Antibacterial
11. Abyssomicins
12. Frigocyclinone
13. Gutingimycin
14. Helquinoline
15. Himalomycins
16. Maklamicin
17. Lobophorin K
18. Asenjonamide C
Antibacterial and anticancerous
19. 1-hydroxy-1-norresistomycin
Antifungal and antibacterial
20. Bonactin
Antiprotease and anticancerous
21. Diazepinomicin (ECO-4601)
Aspergillus aureofaciens Streptomyces sp.
Streptomyces sp.
Streptomyces sp.
Actinomadura sp.
Salinisporatropica
Streptomyces fradiae
Niphatesolemda
Arthrinium sp.
Lissoclinumcf. badium
Aspergillus sp.
Verrucosispora sp. Blocks p-aminobenzoic acid (chorismate) route
Streptomyces griseus
Streptomyces sp.
Janibacterlimosus
Streptomyces sp.
Micromonosporasp.strain
Streptomyces sp. strain M-207
Streptomyces asenjoniistrain KNN 42
Streptomyces variabilis In vitro cytotoxicity against HMO2 (gastric adenocarcinoma) and HePG2
Streptomyces sp.
Micromonosproa sp.
GMKU326
Cytotoxicity against a range of tumor cells
Activity against cancer cell lines
Anticancer activity across multiple cancer cell lines in humans
Cancer cell-line cytotoxicity and Gram-positive bacteria-killing potential
Proteasome and NF-B inhibition
Anticancer activity
Blocker of the p53-Hdm2/Mdm2 interaction
Blocker of p53/Mdm2 binding
Destroys wild-type p53-altered cells
Inhibitory effects on ubiquitin-activating enzyme (E1)
Kaposi’s sarcoma-associated herpes virus inhibitor
Activities against bacteria, fungi, and microalgae
Activities against bacteria, fungi, and microalgae
Activities against Gram-positive bacteria
Inhibition of the growth of Gram-positive bacteria
Ac as antibiotic for Gram-positive pathogens
Antimicrobial for Gram-positive pathogens
(hepatic cancer) cell lines
Inhibited Gram-positive bacteria and fungi
Broad-spectrum preliminary anticancer, antioxidant, and antiprotease activity
⏎
284

285
prospective chemotherapeutic drugs derived from natural sources is still being undertaken
today (Gallagher and LeRoith, 2020).
In the later stages of the development of cancer, antioxidants are very necessary. Even
though the particular mechanisms underlying this are still being investigated, there is
a growing body of evidence that oxidative processes have a role in the development of
cancer. Antioxidants have the potential to stop the spread of precancerous lesions and their
development into cancer. Early research indicates that β-carotene and other antioxidants
might be advantageous in dealing and anticipation of oral leukoplakia, which is a disorder
that has the potential to progress into mouth cancer. It is well recognized that natural foods
are high in β-carotene, α-tocopherol, and vitamins C and E. This indicates that plant extracts
and isolated components of plant origin may be examined for their potential antioxidative
and anticancer activities, which might lead to the creation of new anticancer medicines
(Vishwakarma and Piddini, 2020).
13.4 ANTICANCER AGENTS FROM MARINE FLORAS
The use of novel bioactive compounds found in marine microorganisms is anticipated
to result in the development of new medicines and targets. Bryostatins, discodermolide,
eleutherobin, and sarcodictyin are only a few examples of the innovative anti-inflammatory ,
anticancer, and antibiotic medicinal compounds that have been made from secondary
metabolites generated by marine bacteria (e.g., marinone). By producing bacteriocines,
an antibacterial protein, and other anticancer compounds, probiotic bacteria such as
lactobacilli and bifid bacteria play foremost responsibilities in the regulation of pathogenic
germs. According to reports, lactobacilli dietary supplements reduce the development
of experimental colon cancer. By acting on NF-B pathways, dendritic cell maturation is
influenced and anti-inflammatory cytokines such as IL-10 that horde defence peptides
such as defensing 2 are produced at a higher rate. IgA defences are also strengthened.
Cellular response to short-chain fatty acids is another mechanism by which they regulate
cell growth and death (Varijakzhan et al., 2021). The majority of marine animal phyla
create poisons, and research suggests that the marine bacteria that live with the animals
may also be producing these toxins. Studies on neurophysiology and neuropharmacology
may benefit from the microbial poisons. For instance, crimson tides are brought on by
bacteria found in Noctiluca scintillans. Macrolactin-A is a primary metabolite that inhibits
the growth of B16-F10 murine melanoma cancer cells and types I and II of mammalian
herpes simplex virus. It also protects T lymphocytes from HIV replication. In Hawaii, the
mollusk Elysia rubefescens produced depsipeptides known as kahalalide F (KF), which is
thought to have been produced by microorganisms connected to animals. KF demonstrates
intriguing selectivity in its activity against solid tumors when evaluated in vitro on prostate
cancer cell lines. Extensive in vivo studies also reveal drug’s efficacy in treating colon and
breast cancers. Because very few marine microorganisms are amenable to isolation in the
laboratory , there is a pressing need to establish new culture methods for the identification of
slow-growing bacteria and bacteria that are unique in producing novel natural compounds
(Ghosh et al., 2022).

286
13.5 MECHANISM OF ANTICANCEROUS ACTIVITY EXHIBITED BY MARINE
PLANTS
It is generally accepted that DNA damage plays an important role in the mechanism through
which cancer develops. It would be helpful to have a measurement of the mutagenic DNA
damage to estimate the risk of cancer in different populations and to monitor property of
chemoprevention. The oxidative component is responsible for the vast majority of these
issues. Repairing the majority of the damage is the job of enzymes that work on repairing
DNA. The accumulation of the free radical damage to DNA that occurs with ageing makes
it more probable that a person may get cancer (Fayed et al., 2021).
13.5.1 ANTIOXIDANTS
The human body is equipped with a variety of defense mechanisms that it uses to combat
free radicals and reactive oxygen species (ROS). Because different defenses act on various
classes of oxidants or in various compartments of the cell, they are mutually supportive of
one another. In most circumstances, the presence of high amounts of superoxide dismutase
(SOD) maintains levels of superoxide that are not sufficient to prevent the formation of
Peroxynitrite. Although glutathione (GSH) is not a food, it exists in all the aerobic tissues
because it can be synthesized from sulfhydryl group containing amino acids. It has a very
significant role in the metabolic process of antioxidant intermediates. Consuming nutritious
foods on a regular basis is critical for the proper functioning of enzymes that shield the
body from damaging effects of free radicals (Carreira-Casais et al., 2021). A few instances
of essential components required for the structure or catalytic functions of such enzymes
are selenium, copper, manganese, and zinc. Vitamin E, on the other hand, is not associated
with the activity of any single-enzyme system. Vitamin E functions as an antioxidant by
eliminating free radicals and preserves the structural integrity of phospholipid and lipid
membranes. V itamin E has a significant impact on other antioxidants already present in the
body , for instance, GSH and vitamin C. Evidence is mounting that vitamin E can influence
cellular processes like gene expression and inflammatory response. Vitamin C is also a
potent antioxidant since it may donate an electron of hydrogen in exchange for the formation
of the comparatively stable ascorbyl free radical or L-ascorbate anion. It has been shown
that ascorbate is an effective reactive oxygen species scavenger against singlet oxygen,
hydrogen peroxide, hydroxyl radical, and superoxide radical anion. In addition, dangerous
nitrogen oxide species are also eliminated by vitamin C. To prevent the target molecules
from getting nitrosated, it works in this way. Ascorbyl has the potential to undergo further
oxidation, which would result in the formation of dehydroascorbate. Alternatively, it might
acquire an additional hydrogen atom and transform into reduced ascorbate. Ascorbate is
more water-soluble than dehydroascorbate, and erythrocytes absorb dehydroascorbate
10–20 times more quickly than ascorbate. The hexose monophosphate shunt then converts
it back into ascorbate, either via GSH or Nicotinamide adenine dinucleotide phosphate
(NADPH). Therefore, there is no limit to the mechanisms in which vitamin C can be used.
Tissue metabolism generates free radicals, but the cell’s antioxidant capacity and its repair

287
systems work together to limit their damage. So, a healthy individual who consumes an
enough amount of food and has tissue cells that are metabolically active will have little
tissue damage, and if damage does occur, the majority of it will be cured (Xu et al., 2021).
13.5.2 IMMUNOMODULATION AND APOPTOSIS
The intricate process of apoptosis causes a variety of alterations in the dying cells and
utilizes several signaling channels. A change in the ratio of anti- and pro-apoptotic proteins
activates apoptotic machinery. Apoptosis may be reduced by upregulating antiapoptotic
proteins, downregulating proapoptotic proteins, and downregulating caspase expression. It is
known that evading apoptosis speeds up the growth of cancer by preventing differentiation.
In conditions when there is inadequate apoptosis, which results in cancer, dysregulation of
apoptotic signaling may be very important. Caspase 8 is a mitochondrial initiator caspase
that promotes cytochrome C release and links death receptor with mitochondrial pathways
of apoptosis. Caspase 3 is a cell-killing effector caspase that is required for cell survival.
Apoptosis induction is a promising strategy for inhibiting cancer cell proliferation (Matulja
et al., 2022). Cancer has been treated with radiation and chemicals such as tamoxifen, which
may induce apoptosis. Several chemo-preventive substances cause apoptosis to have an
anticarcinogenic effect. Plant extracts’ ability to induce apoptosis of malignant cells may be
linked to upregulated immune surveillance, an increase in macrophages, and activation of
signal complexes that cause death. Malignant cells have been shown to undergo apoptosis
in vitro when exposed to natural food components such as curcumin and resveratrol. The
macrophages may be stimulated and made to undergo apoptosis by the marine phytochemicals
(Yao et al., 2022). Fucoidan, an immunomodulator that directly affects macrophage and T
lymphocyte, is derived from the Laminaria japonica plant and may restore the immunological
capabilities of immunosuppressed mice. In rats exposed to radiation, it may also encourage
the restoration of immune function. The mechanism is connected to the fucoidans ability
to stop lymphocyte apoptosis. Dendritic cells that are potent antigen-presenting cells are
affected by fucoidan from Focus vesiculosus in an immunostimulant and growing method
via a nuclear factor-B route (NF-κB) (Yarley et al., 2021).
13.5.3 NUTRITIONAL VALUES AND ANTICANCER EFFECTS
Marine plants are expected to meet the need for food and nutrients for handling human
ailments. The majority of cancer-preventive diets focus on including foods that come from
plants as their primary source of nutrition. A higher frequency of consumption of a wide
variety of plant foods is recommended for cancer prevention. “Plant-based” diets place more
emphasis on nutrient-dense, fiber-rich (and thus, nonstarch polysaccharide-rich), and caloriepoor foods. Consuming a diet rich in fruits and vegetables that are low in starch may reduce the
risk of developing some cancers. Seaweeds are often ingested by people and have been used
medicinally for a very long time. Seaweeds possess many unique biological features against
tuberculosis, arthritis, colds, influenza, cancer, and so on (Yusefi
et al., 2020).

288
Most of individuals unknowingly utilize products containing seaweed on a daily
basis. Many processed foods, particularly processed dairy, meat, and fruits, contain these
substances. Other common products that contain them include paint, dental products, and
even some paints. Seaweeds are an outstanding source of several nutrients, including the
minerals calcium, phosphorus, sodium, and potassium, and vitamins. They have a healthy
mix of amino acids and contain almost all of the essential amino acids necessary for
survival and good health. They possess more than 54 trace elements, which are essential for
the physiological processes that take place in the human body (Gopeechund et al., 2020).
13.6 NATURE AND CANCER CHEMOTHERAPY
According to recent studies conducted during the last half-century, it has been observed
that several natural chemicals originating from marine plants and microorganisms have
been shown to be effective for the treatment and prevention of cancer . Cytarabine, eribulin
mesylate, brentuximab vedotin, and trabectedin are only a few of the drugs that have been
originated from marine sources. These drugs are administered to the patients depending
upon the type of cancer being treated. There are other important terrestrial sources of
anticancer medicines including plants, animals, invertebrates, and microorganisms.
Vincristine and vinblastine both of which are active complex alkaloid chemicals found
in the Vinca plant when combined with antineoplastic drugs such as taxol that originate
from the outer layer of the bark of Western Yew tree have shown promising results in
the treatment of breast cancer. It has been shown that both vincristine and vinblastine
are effective therapies for juvenile leukemia as well as for choriocarcinoma that is a
cancer of the lymph nodes caused by Hodgkin’s disease (Okem et al., 2023). Traditional
medical practices for treating a wide range of conditions historically made extensive
use of natural compounds derived from plants. With the advent of “modern” medicine,
which is found through scientific research, natural remedies that are plant-based have
been subjected to intense scrutiny due to the lack of empirical evidence supporting their
effectiveness. Despite this, researchers have kept seeking for systematic verification to
support the use of functional meals, therapeutic plants, and herbal medications. Because
of the emphasis on the research and development of medicinal plant-based active principles in recent decades, a significant amount of headway has been achieved in both the
discovery and the use of naturally occurring compounds in the treatment of a wide range
of illnesses (Figure 13.2). The knowledge about medicinal plants and the therapeutic
properties they possess originates from either traditional Chinese or Indian medicine.
Approximately, 25–28% of the modern drugs used by humans, including those used to
treat cancer, have been obtained either directly or indirectly from plants or other natural
sources (Yahyea Baktiar et al., 2020).
Global economic and social systems have largely been impacted by cancer, as it is the
leading cause of mortality worldwide. It is necessary to develop cancer prevention strategies
for those who are at risk and to improve cancer treatment strategies for individuals who
have already been diagnosed with the condition. There is a very small fraction of cancer
cases that may be attributed to hereditary or genetic vulnerability . Cancers typically develop

289
over a period of years or even decades, and their onset can be attributed to a wide range
of causes. These causes include DNA damage, epigenetic changes, metabolic changes,
persistent inammation, and interactions between abnormal molecular pathways, apoptosis
inhibition, and cellular communication with nearby tissues. Surprisingly, natural chemicals
that are derived from plants have the potential to target one or more of the mechanisms that
induce neoplasticity (Figure 13.1). By doing so, these natural substances may be able to stop
cancer from initiating, developing, spreading, or relapsing (Shen et al., 2021).
Despite the strong chemical reasoning, cancer chemoprevention employing marine
natural chemicals has not been explored extensively, and clinical and preclinical data for
this technique is limited. Plants, bacteria, and marine organisms are the biological sources
that have yielded chemicals with anticancer characteristics that have been recognized
and synthesized. As a consequence, abundant natural products are now being considered
in preclinical research, and 13 natural compounds derived from marine organisms are
presently being considered in clinical trials at varying levels. These recent advancements
highlight the potential of natural compounds found in marine environments. It has been
hypothesized that a focused and combinatorial approach might speed up the expansion of
innovative anticancer agents resulting from marine resources that are more effective and
have fewer side effects (Figure 13.2).
FIGURE 13.1 Pharmacological effects of natural compounds in various diseases.
Source: Reprinted from Samuel
https://creativecommons.org/licenses/by/4.0/
et al. (2021). Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
⏎

290
FIGURE 13.2 Natural sources with anticancer compounds.
Source:
Adapted from Khalifa et al. (2019). Copyright © 2019 by the authors. Licensee MDPI, Basel,
Switzerland. http://creativecommons.org/licenses/by/4.0/
⏎
13.7 MARINE ORGANISMS AND CANCER CHEMOTHERAPY
Much effort has been put to discover new anticancer medicines that originate from natural
sources due to the pressing need for anticancer therapeutics with novel mechanisms of
action. Some examples of these natural resources are marine life, bacteria, and plants.
Marine populations operate as a reservoir for new bioactive metabolites (Santaniello et al.,
2023). In this chapter, the importance of marine organisms, marine sponges, and other
marine organisms including soft corals, seaweeds, algae, bacteria, actinomycetes, and fungi
has been described in preventing growth of tumors, as well as the associated compoundinduced apoptosis and cytotoxicity. In addition to this, several molecular routes leading
to the biological effects have been discussed. The use of marine-derived components in
therapeutic procedures, in addition to its present state and possible future prospects, has
also been discussed (Figure 13.3).
There are approximately 500 × 106 different species of prokaryotic and eukaryotic
creatures that are known to exist in the earth. The marine environment is home to an
30
estimated 3.7 × 10
microorganisms. To protect themselves from predators and harsh
environmental circumstances such as high temperatures, high salinity, and high pressure,
marine organisms develop secondary metabolites (Sekar et al., 2022).

291
Sea plants have been used for their therapeutic value by Asia, the Middle East, and
Europe for endless millennia. Since that time, scientists have only investigated around 5%
of the deep water, and only approximately 1% of the ocean bottom has been thoroughly
researched. Chemical study on marine species did not get started until after substantial
work was done on the Caribbean sponge (Cryptotethya crypta). In the years 1950 and
1960, scientists used phytochemical methods to investigate the pure substances that might
be extracted from this plant (Ara-C). In addition, a number of marine creatures including
bacteria, actinobacteria, cyanobacteria, fungi have been studied to see whether or not they
possess any potential anticancer properties. In clinical studies, the effectiveness of bioactive compounds against a variety of cancer forms has been investigated and analyzed. In
addition, as marine chemistry advances, new technologies such as metabolomics are being
used to analyze marine products (Püsküllüoğlu and Michalak, 2022).
Approximately 22,000 secondary metabolites have been reported to be produced by
microbes, with actinomycetes producing 70%, fungi producing 20%, Bacillus sp. producing
7%, and other bacteria contributing 1%–2% of these compounds. It is important to keep
in mind that microbes are generally the source of 10% of all naturally occurring biologically active chemicals that are currently being recognized. There are few marine anticancer
medicines that have been tested successfully in clinical trials. Second phase of bryostatin
1 clinical study has begun assessing the drug’s effectiveness against malignancies of the
colon, kidney, non-Hodgkin’s lymphoma, and skin. Bryostatin 1 encourages the production of progenitor cells in bone marrow. In addition, the peptide dolastatin 10, which was
derived from the mollusk Dollabella auricularia, has progressed to phase II clinical trial
stage owing to its ability to prevent the construction of microtubules, which eventually leads
to metaphase arrest in T cells (Montuori et al., 2022).
13.8 ANTICANCER AGENTS FROM MARINE FLORAS
Marine algae make up 65.63% of all the anticancer compounds that have been discovered
so far, with mangroves coming in second with 28.12% and bacteria coming in third with
6.25%. Because of the complex chemical ecology of marine organisms, including marine
flora, there is a significant possibility that marine species, in particular marine flora, could
be used to develop anticancer drugs that are effective, affordable, and safe.
13.9 MARINE PLANTS
Algae make up more than 90% of all marine plant species (Abdelhamid et al., 2020).
13.9.1 MACRO ALGAE (SEAWEED)
In addition to providing essential nutrients such as protein and iodine, seaweeds’ metabolites
have demonstrated promising anticancer benefits. Within the past three decades, there have

292
been a number of investigations into the antioxidant, anticancer, and immunomodulatory
properties of seaweeds. It has been shown that certain types of edible seaweed such as
Palmaria palmate are rich in antioxidants that inhibit the development of cancer cells. Red
algae Acanthophora spicifera has tumorcidal activity on mice that have developed Ehrlich’ s
ascites carcinoma cells at dosage of 20 mg/kg, which is comparable to conventional medicine
5-flurouracil in terms of its anticancer effects. This is shown by the longer median survival
time, lower tumor volume, and higher viable cell count. In smear examination, membrane
blebbing, the creation of vacuoles, and a reduction in staining intensity may be recognized
as further indications of tumorcidal activity (Singh et al., 2020) (Figure 13.3).
FIGURE 13.3 Marine drugs and compounds utilized in clinical trials, its sources, and chemical classes.
Source: Reprinted from El-Bondkly
et al. (2021). Copyright © 2021 The Authors. Published by Elsevier Ltd.
13.9.2 MANGROVES AND OTHER HIGHER PLANTS
Fisher-folk medicine has historically employed mangroves to heal illnesses. 2-benzoxazoline ribose derivative of Acanthus ilicifolius has been studied for its antiviral and anticancer effects. Ceriops decandra tea has been demonstrated to reduce dimethyl Benz [a]
anthracine-induced buccal pouch carcinogenesis in hamsters (Denny, 2021).
Соседние файлы в папке Библиотека им академика М.И. Перельмана
